Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE1750.05119.3 (+7.32 %)

PREV CLOSE ( ) 1630.75

OPEN PRICE ( ) 1682.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 13807

TODAY'S LOW / HIGH ( )1657.70 1844.00

52 WK LOW / HIGH ( ) 6351999

NSE

This Company is not listed in NSE

Select year

Particulars

Mar 2025

Operational & Financial Ratios

Earnings Per Share (Rs)

41.80

CEPS(Rs)

52.48

DPS(Rs)

0.70

Book NAV/Share(Rs)

299.43

Tax Rate(%)

28.20

Margin Ratios

Core EBITDA Margin(%)

11.56

EBIT Margin(%)

10.99

Pre Tax Margin(%)

6.06

PAT Margin (%)

4.35

Cash Profit Margin (%)

5.46

Performance Ratios

ROA(%)

4.05

ROE(%)

13.96

ROCE(%)

16.16

Asset Turnover(x)

0.93

Sales/Fixed Asset(x)

5.63

Working Capital/Sales(x)

4.54

Efficiency Ratios

Fixed Capital/Sales(x)

0.18

Receivable days

142.46

Inventory Days

192.94

Payable days

160.10

Valuation Parameters

PER(x)

15.99

PCE(x)

12.74

Price/Book(x)

2.23

Yield(%)

0.10

EV/Net Sales(x)

1.05

EV/Core EBITDA(x)

8.70

EV/EBIT(x)

9.58

EV/CE(x)

1.55

M Cap / Sales

0.70

Growth Ratio

Net Sales Growth(%)

0.00

Core EBITDA Growth(%)

0.00

EBIT Growth(%)

0.00

PAT Growth(%)

0.00

EPS Growth(%)

0.00

Financial Stability Ratios

Total Debt/Equity(x)

1.18

Current Ratio(x)

1.30

Quick Ratio(x)

0.57

Interest Cover(x)

2.23

Total Debt/Mcap(x)

0.53